Table 1:
Patient and Donor Demographics
| e-SD | d-SD | Hypofibrinolysis | P Value | |
|---|---|---|---|---|
| Age (Years) | 60 (54-63) | 55 (50-65) | 52 (44-63) | 0.221 |
| Female | %55 | 45% | 41% | 0.665 |
| HCC | 13% | 22% | 39% | 0.181 |
| BMI | 26 (23-30) | 26 (24-29) | 27 (25-32) | 0.637 |
| Pre-op INR | 2.2 (1.5-3.0) | 2.0 (1.5-2.9) | 2.0 (1.4-2.5) | 0.651 |
| Pre-op Plt (100,000) | 54 (39-70) | 63 (36-96) | 65 (40-133) | 0.200 |
| Pre-op LY30 (%) | 0 (0-0.1) | 0 (0-0.5) | 0 (0-0.2) | 0.811 |
| MELD | 25 (18-33) | 23 (16-36) | 20 (13-31) | 0.423 |
| Warm Ischemia Time (Minutes) | 32 (30-36) | 39 (34-44) | 34 (30-40) | 0.004 |
| Cold Ischemia Time (Minutes) | 336 (284-370) | 361 (284-420) | 430 (319-542) | 0.130 |
| Donor Age (Years) | 38 (21-44) | 40 (31-46) | 32 (21-49) | 0.403 |
| Donor Female | 32% | 39% | 28% | 0.811 |
| Donor BMI | 25 (23-31) | 30 (25-33) | 24 (22-28) | 0.078 |
e-SD = Early Shutdown, d-SD= Delayed Shutdown, HCC= Hepatocellular Carcinoma, BMI = Body Mass Index, PLT = Platelet Count, MELD = Model for End Stage Liver Disease, P Value represents Kruskal Wallis test across three groups or Chi Square for categorical variables.